Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobs, L.
Right arrow Articles by Kaba, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobs, L.
Right arrow Articles by Kaba, S. E.
NEUROLOGY 1991;41:15
© 1991 American Academy of Neurology

Clinical and magnetic resonance imaging in optic neuritis

Lawrence Jacobs, MD, Frederick E. Munschauer, MD and Samer E. Kaba, MD

Baird Multiple Sclerosis Research Center. State University of New York School of Medicine at Buffalo, Buffalo, NY.

We found 23 of 48 patients (48%) with isolated monosymptomatic optic neuritis (ON) to have 1 to several brain lesions by MRI. All the brain lesions were clinically silent and had characteristics consistent with multiple sclerosis (MS). During 4 years of follow-up, 9 patients (19%) developed definite MS on clinical grounds. Six of the converting patients had abnormal MRIs; the other 3 had MRIs that were normal both initially (when they had ON only) and when repeated after they had developed MS. The other 17 patients with abnormal MRIs have not developed symptoms or signs of MS during follow-up. Thus, an abnormal MRI does not auger development of clinical MS within a mean of 4 years, nor does a normal MRI protect against development of disseminated disease. It is not prudent to give a patient with isolated monosymptomatic ON the diagnosis of MS (probable or definite) because of an abnormal MRI (with or without other laboratory abnormalities).

Address correspondence and reprint requests to Dr. Lawrence Jacobs, Department of Neurology, Buffalo General Hospital. 100 High Street, Buffalo, NY 14203.

Supported by the William C. Baird Multiple Sclerosis Research Endowment.

Received June 12,1990. Accepted for publication in final form September 6,1990.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
D.A. Jacobs and S.L. Galetta
Neuro-Ophthalmology for Neuroradiologists
AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 3 - 8.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
Optic Neuritis Study Group
Long-term Brain Magnetic Resonance Imaging Changes After Optic Neuritis in Patients Without Clinically Definite Multiple Sclerosis
Arch Neurol, October 1, 2004; 61(10): 1538 - 1541.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Minneboo, F. Barkhof, C. H. Polman, B. M. J. Uitdehaag, D. L. Knol, and J. A. Castelijns
Infratentorial Lesions Predict Long-term Disability in Patients With Initial Findings Suggestive of Multiple Sclerosis
Arch Neurol, February 1, 2004; 61(2): 217 - 221.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. M. Frohman, D. S. Goodin, P. A. Calabresi, J. R. Corboy, P. K. Coyle, M. Filippi, J. A. Frank, S. L. Galetta, R. I. Grossman, K. Hawker, et al.
The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology, September 9, 2003; 61(5): 602 - 611.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
Y P Jin, J de Pedro-Cuesta, Y H Huang, and M Soderstrom
Predicting multiple sclerosis at optic neuritis onset
Multiple Sclerosis, April 1, 2003; 9(2): 135 - 141.
[Abstract] [PDF]


Home page
NeurologyHome page
D. I. Kaufman, J. D. Trobe, E. R. Eggenberger, and J. N. Whitaker
Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology, June 13, 2000; 54(11): 2039 - 2044.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J I O'Riordan, N A Losseff, C Phatouros, A J Thompson, I F Moseley, D G MacManus, W I McDonald, and D H Miller
Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination
J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 353 - 357.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
D. Miller
Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force
Multiple Sclerosis, June 1, 1996; 1(6): 335 - 338.
[Abstract] [PDF]


Home page
Arch NeurolHome page
L. Jacobs, S. Kaba, and P. Pullicino
The Lesion Causing Continuous Facial Myokymia in Multiple Sclerosis
Arch Neurol, November 1, 1994; 51(11): 1115 - 1119.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. E. Goodkin, R. A. Rudick, and J. S. Ross
The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Arch Neurol, May 1, 1994; 51(5): 505 - 516.
[Abstract] [PDF]


Home page
NEJMHome page
R. W. Beck, P. A. Cleary, J. D. Trobe, D. I. Kaufman, M. J. Kupersmith, D. W. Paty, C. H. Brown, and The Optic Neuritis Study Group
The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple Sclerosis
N. Engl. J. Med., December 9, 1993; 329(24): 1764 - 1769.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
R. W. Beck, J. Arrington, F. R. Murtagh, P. A. Cleary, D. I. Kaufman, and Optic Neuritis Study Group
Brain Magnetic Resonance Imaging in Acute Optic Neuritis: Experience of the Optic Neuritis Study Group
Arch Neurol, August 1, 1993; 50(8): 841 - 846.
[Abstract] [PDF]


Home page
NEJMHome page
R. R Edelman and S. Warach
Magnetic Resonance Imaging- First of Two Parts
N. Engl. J. Med., March 11, 1993; 328(10): 708 - 716.
[Full Text]


Home page
Arch OphthalmolHome page
Optic Neuritis Study Group
The Clinical Profile of Optic Neuritis: Experience of the Optic Neuritis Treatment Trial
Arch Ophthalmol, December 1, 1991; 109(12): 1673 - 1678.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by AAN Enterprises, Inc.